VKH
ATYR

Virtu KCG Holdings’s aTyr Pharma ATYR Stock Holding History

Virtu KCG Holdings’s Portfolio ATYR Stock Details ATYR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		$36K Buy
+762
New +$35.7K ﹤0.01% 2654
2017
Q1 		– Sell
-1,425
Closed -$43K – 3828
2016
Q4 		$43K Buy
+1,425
New +$58.5K ﹤0.01% 3123

Other funds holding ATYR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
PVMCV
Polaris Venture Management Co V Boston, Massachusetts $14.1M AUM 121.41% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
GHCM
Glen Harbor Capital Management San Diego, California $4.82B AUM 4.69% 1-Year Est. Return
MCIM
Meadow Creek Investment Management Atlanta, Georgia $5.09B AUM 5.82% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Virtu KCG Holdings's ATYR Position: Q2 2017 in Review

Virtu KCG Holdings opened a new position in aTyr Pharma (ATYR) in Q2 2017: 762 shares worth $36K. The stake represents ﹤0.01% of the portfolio and ranks #2654 among its holdings. This is a return to the name: Virtu KCG Holdings previously reported a position in ATYR as recently as Q4 2016.

Virtu KCG Holdings first reported a position in ATYR in Q4 2016 and has held it in 2 quarters since. The position peaked at $43K in Q4 2016. 32 funds tracked by Wall St. Rank hold ATYR as of Q2 2017.

  • Virtu KCG Holdings held 762 shares of aTyr Pharma worth $36K as of Q2 2017.
  • aTyr Pharma was a new Virtu KCG Holdings position in Q2 2017.
  • aTyr Pharma made up ﹤0.01% of Virtu KCG Holdings's portfolio in Q2 2017, its #2654 holding.
  • Virtu KCG Holdings first reported a position in aTyr Pharma in Q4 2016 and has held it in 2 quarters since.
  • Virtu KCG Holdings's aTyr Pharma position peaked at $43K in Q4 2016.
  • 32 funds tracked by Wall St. Rank held aTyr Pharma as of Q2 2017.

Based on Virtu KCG Holdings's 13F filing for Q2 2017, filed 11 Aug 2017.